EYE 8.62% 26.5¢ nova eye medical limited

Nova Eye Medical (EYE) Discussion, page-1868

  1. 1,235 Posts.
    lightbulb Created with Sketch. 25
    Morning TA007, correct me if I’m wrong but I didn’t think reimbursements actually stopped, so I’m assuming sales wouldn’t have been impacted for ITrack procedures. they were planned to stop after Dec 24th but that never came into play. Keen for your thoughts

    Proposed USA Medicare ChangesHighlights• Local coverage determination (LCD) changes proposed for Medicarereimbursement of MIGS procedures in Kansas, Nebraska, Missouri, Iowa,Indiana and Michigan, is not expected to have an impact on sales.• The impact of the LCD on the Company’s revenues is dependent upon thesurgical technique deployed by surgeons when using the Company’s iTrack™portfolio.• Should the LCD be implemented, the Company’s iTrack™ portfolio may have noreimbursement coverage for the ab interno canaloplasty surgical technique inthose states from December 24, 2023. The use of iTrack™ for the ab externosurgical technique is expected to maintain coverage beyond December 24,2023.• The Company’s Molteno3® portfolio will maintain coverage.• The Company’s technology platform and intellectual property portfolio,provides an opportunity to adapt to the proposed changes, take advantage ofmarket consolidation and, ultimately, maintain sales and sales growth.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
-0.025(8.62%)
Mkt cap ! $60.63M
Open High Low Value Volume
29.0¢ 29.5¢ 26.5¢ $332.8K 1.182M

Buyers (Bids)

No. Vol. Price($)
6 121450 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 154073 4
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.